Avenue Therapeutics, Inc. (ATXI)
NASDAQ: ATXI · IEX Real-Time Price · USD
0.153
+0.002 (1.06%)
At close: Mar 27, 2024, 4:00 PM
0.150
-0.003 (-1.77%)
Pre-market: Mar 28, 2024, 6:54 AM EDT
Avenue Therapeutics Stock Forecast
ATXI's stock price has decreased by -85.87% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Avenue Therapeutics stock have an average target of 16.38, with a low estimate of 0.75 and a high estimate of 32. The average target predicts an increase of 10,633.94% from the current stock price of 0.15.
Analyst Consensus: Strong Buy
* Price targets were last updated on Dec 11, 2023.
Analyst Ratings
The average analyst rating for ATXI stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 |
---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 |
Buy | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 |
Total | 2 | 2 | 2 | 2 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Maxim Group | Maxim Group | Strong Buy Initiates $0.75 | Strong Buy | Initiates | $0.75 | +391.48% | Dec 11, 2023 |
Aegis Capital | Aegis Capital | Strong Buy Initiates $32 | Strong Buy | Initiates | $32 | +20,869.86% | Apr 3, 2023 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates n/a | Strong Buy | Initiates | n/a | n/a | Jun 25, 2018 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.42
from -0.98
EPS Next Year
-0.38
from -0.42
Revenue Forecast
Revenue |
---|
High |
Avg |
Low |
Revenue Growth
Revenue Growth |
---|
High |
Avg |
Low |
EPS Forecast
EPS | 2024 | 2025 |
---|---|---|
High | -0.43 | -0.39 |
Avg | -0.42 | -0.38 |
Low | -0.40 | -0.36 |
EPS Growth
EPS Growth | 2024 | 2025 |
---|---|---|
High | - | - |
Avg | - | - |
Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.